Andrew Udell

All filings by Andrew Udell on record concern Calliditas Therapeutics AB. The record holds 5 filings, for trades running from 10 July 2019 to 20 December 2022.

Both buying and selling appear: 1 purchase worth €18k, against 2 sales worth €135k. Taken together, the sales exceed the purchases by €117k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2022 alone, the filings show no purchases and 2 sales.

On 23 December 2022 came the latest disclosure, an open-market sale for €31k in Calliditas Therapeutics AB. The last purchase on record was published on 11 July 2019, which is 2,678 days ago. The median gap between a trade and its publication by Finansinspektionen is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.